Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy variable 1-12 (IGHV1-12)
- Target
- IGHV1-12
- Molecular classification
- Immunoglobulin variable region, Pseudogene, Gene segment
01
Overview
The immunoglobulin heavy variable 1-12 (IGHV1-12) gene is a member of the immunoglobulin heavy variable (IGHV) gene family, which encodes variable regions of immunoglobulin heavy chains essential for the diversity of antibodies. IGHV1-12 in humans is annotated as a pseudogene, meaning it does not encode a functional variable region protein due to disruptions in its coding sequence[1]. The broader IGHV locus undergoes somatic rearrangement in B cells to generate the diverse repertoire of antibodies crucial for adaptive immunity; however, as a pseudogene, IGHV1-12 does not contribute functional variable domains to immunoglobulins. IGHV gene polymorphisms can influence immune responses and disease susceptibility in general, but IGHV1-12 specifically has not been implicated as a disease biomarker or therapeutic target[1][2][3].
- Other names
- 1-12PIGHV112IGHV1-12
02
Mechanism of action
None. Not a target for pharmacologic action.
03
Biological functions
Antigen recognition (as part of immunoglobulin heavy chain repertoire, though as a pseudogene, does not directly contribute functional protein)[1][2]Generation of antibody diversity (general role of the IGHV family, but this specific segment is nonfunctional)[1]
04
Disease associations
Other (germline polymorphisms in IGHV regions may influence disease susceptibility, but specific data on IGHV1-12 is absent due to its pseudogene status)[2]
Beyond the preview
Go deeper on Immunoglobulin heavy variable 1-12 (IGHV1-12).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immunoglobulin heavy variable 1-12 (IGHV1-12).